Agios Highlights Key 2019 Initiatives to Broaden Potential for Cancer and Rare Genetic Disease Programs to Build Long-Term Value Read more about Agios Highlights Key 2019 Initiatives to Broaden Potential for Cancer and Rare Genetic Disease Programs to Build Long-Term Value
Agios to Present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019 Read more about Agios to Present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019
Q4 2018 Agios Pharmaceuticals Inc Earnings Conference Call Read more about Q4 2018 Agios Pharmaceuticals Inc Earnings Conference Call
Agios Presents Updated Data from the Ivosidenib Phase 1 Dose-Escalation and Expansion Trial in IDH1 Mutant Positive Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Ineligible for Standard Treatment and Myelodysplastic Syndrome (MDS) Read more about Agios Presents Updated Data from the Ivosidenib Phase 1 Dose-Escalation and Expansion Trial in IDH1 Mutant Positive Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Ineligible for Standard Treatment and Myelodysplastic Syndrome (MDS)
Agios Announces Updated Data from Phase 1 Study of Ivosidenib or Enasidenib in Combination with Standard Induction and Consolidation Chemotherapy in Newly Diagnosed AML Patients With an IDH Mutation Read more about Agios Announces Updated Data from Phase 1 Study of Ivosidenib or Enasidenib in Combination with Standard Induction and Consolidation Chemotherapy in Newly Diagnosed AML Patients With an IDH Mutation
Agios Presents Updated Data from Phase 1 Dose-Escalation Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma Read more about Agios Presents Updated Data from Phase 1 Dose-Escalation Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma
Agios to Present Updated Clinical Data at the 2018 ASH Annual Meeting Read more about Agios to Present Updated Clinical Data at the 2018 ASH Annual Meeting
Agios Reports Third Quarter 2018 Financial Results Read more about Agios Reports Third Quarter 2018 Financial Results
Q3 2018 Agios Pharmaceuticals Inc Earnings Conference Call Read more about Q3 2018 Agios Pharmaceuticals Inc Earnings Conference Call
Agios to Webcast Conference Call of Third Quarter 2018 Financial Results on November 1, 2018 Read more about Agios to Webcast Conference Call of Third Quarter 2018 Financial Results on November 1, 2018